Heilongjiang ZBD Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of Chinese medicines in China. It offers cardiovascular and cerebrovascular, respiratory system, orthopedics, tumors, digestive system, anti-infection, mental nerve, genitourinary, and other disease fields. The company was founded in 1996 and is based in Hulin, China.

Company Data

Name Heilongjiang ZBD Pharmaceutical Co., Ltd.

Company Heilongjiang ZBD Pharmaceutical Co., Ltd.

Website https://www.zbdzy.com

Primary Exchange

SSE

ISIN CNE100002219

Asset Class Share

Sector Healthcare

Industry Drug Manufacturers - Specialty & Generic

CEO Jiujiang Yan

Market Capitalization 12 Mrd.

Country China

Currency CNY

Employees 2,5 T

Address No. 72 Hongxing Street, Hulin

IPO Date 2015-04-24

Ticker Symbols

Name	Symbol
SSE	603567.SS

More Shares

Investors who hold Heilongjiang ZBD Pharmaceutical Co., Ltd. also have the following shares in their portfolio:

NUVEEN ESG EMERGING MARKETS EQUITY ETF ETF

Vanta Bioscience Limited Share

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Community Feedback Changelog